You are here: Industry Insights > teva

News List

Teva conducts boardroom shuffle with four new faces pharmafile
June 13, 2017
Teva Pharmaceutical has four new leaders
500 staff face the axe as Teva cans Hungary plant pharmafile
May 18, 2017
Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, Hungary, leaving 500 staff facing the axe.
Teva Reports First Quarter 2017 Financial Results americanpharmaceuticalreview
May 15, 2017
Teva Pharmaceutical reported results for the quarter ended March 31, 2017.
Teva and Active Biotech Announce Concerto Trial of Laquinimod did not Meet Primary Endpoint americanpharmaceuticalreview
May 09, 2017
Teva Pharmaceutical Industries and Active Biotech announced results from the Concerto trial in patients with relapsing-remitting multiple sclerosis (RRMS).
US FDA approves Teva’s Austedo tablets to treat chorea associated with HD pharmaceutical-technology
April 06, 2017
Teva Pharmaceutical’s Austedo (deutetrabenazine) tablets have been approved by the US Food and Drug Administration (FDA) to treat chorea associated with Huntington’s disease (HD).
Teva Launches Authorized Generic of Minastrin® 24 Fe americanpharmaceuticalreview
March 17, 2017
Teva Pharmaceutical Industries has announced the launch of the Authorized Generic of Minastrin® 24 Fe1 (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) mg/20 mcg in the U.S.
Teva Announces Launch of Generic Pristiq® in the United States americanpharmaceuticalreview
March 03, 2017
Teva Pharmaceutical Industries has announced the launch of generic Pristiq®1 (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the U.S.
Teva freezes plans to build new Ra'anana HQ firstwordpharma
February 27, 2017
Globes reported Saturday that Teva is was suspending the construction of its new headquarters in Ra'anana.
Teva's fourth-quarter sales jump 33 percent, lifted by Actavis generics business purchase firstwordpharma
February 14, 2017
Teva reported Monday that fourth-quarter sales surged 33 percent year-over-year to $6.5 billion, topping analyst estimates of $6.3 billion.
Financial Report: Teva contractpharma
February 14, 2017
Specialty medicines revenues up 4% in the quarter

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page